ciml.bsky.social - Profile | ThreadSky | a Reddit-style client for Bluesky

Check this last paper from the Malissen's lab👇. A gain-of-function CARMIL2 variant can substitute for CD28 costimulation, enabling T cells to bypass PD-1 and CTLA-4 checkpoints. This discovery revisits the architecture of the CD28 costimulatory pathway and opens avenues for next-gen immunotherapies.

submitted 20 days ago • 0 comments

🦠 Check the last study from the team of Philippe Pierre in PNAS @pnas.org. The authors show how a bacterial toxin can hijack our cells’ stress response to trigger immune signals linked to inflammation and infection. Congratulations to all authors!

submitted 27 days ago • 0 comments

Last week we had the great honor to welcome Dr. Eliane Piaggio from Institut Curie in our 2025 CIML seminar series. Eliane gave an interesting seminar on "Single-Cell Treg Profiling: New Cancer Therapies and Insights into Tumor-Treg Biology" and had great exchanges with CIML scientists.

submitted 28 days ago • 0 comments

🧠🦠 Check this Review written by the team of Sophie Ugolini @ugolinis.bsky.social on how sensory neurons modulate immune responses. Just out in Immunity @cp-immunity.bsky.social.

submitted 42 days ago • 0 comments

🔬 🦠 Check this great scientific meeting organized by Carolyn King and CIML's team leader Mauro Gaya. @immunologyking.bsky.social @maurogaya.bsky.social

submitted 47 days ago • 0 comments

🧠🛡️ CIML celebrates the International Day of Immunology 2025: When Brain Meets Immunity. This year, we spotlight two Inserm researchers whose research is transforming our understanding of how the nervous and immune systems interact, paving the way for new therapies for neurological diseases.

submitted 48 days ago • 0 comments

🎉 We're thrilled to share that Dr. Anaïs Rogier, trained at CIML in Sophie Ugolini’s team, has received the Aix-Marseille University Thesis Award for her outstanding work on neuro-immune regulation during viral infections. Bravo Anaïs! 🧠🦠

submitted 60 days ago • 0 comments

In a study led by Jean-Pierre Gorvel and Sylvie Mémet, CIML researchers found that SLAMF receptors shape human plasmacytoid dendritic cell responses to intracellular bacteria. Congrats to 1st author Joaquin Pellegrini and collaborators. www.jci.org/articles/vie... @jclinical-invest.bsky.social

submitted 61 days ago • 1 comment

We are proud to announce that Prof. Eric Vivier @ericvivier.bsky.social, team leader at CIML and former director (2008–2017), has been awarded the prestigious Léopold Griffuel Prize for "Translational and Clinical Research" by the ARC Foundation for Cancer Research. @univ-amu.fr @inserm.fr @cnrs.fr

submitted 61 days ago • 1 comment

Today, we had the pleasure of welcoming Dr. Iñaki Martin Subero from Fundació de Recerca Clínic Barcelona in Spain as part of the 2025 CIML seminar series. Iñaki gave an incredible seminar: “An epigenetic journey to the origin, pathogenesis and evolution of chronic lymphocytic leukemia”.

submitted 67 days ago • 0 comments

Yesterday we organized the CIML Scientific Day dedicated to "Immunology Meets Oncology" The day featured outstanding presentations on the intersection between immunology and cancer research from Bruno Quesnel, Pierre Milpied, Nathalie Auphan-Anezin, Eric Vivier, Carole Siret, and Rafael Argüello.

submitted 73 days ago • 1 comment

Today, we had the pleasure of welcoming Dr. Jakub Abramson from the Weizmann Institute of Science, as part of the 2025 CIML seminar series. Jakub gave a great seminar: “From Thymic Mysteries to Sex hormones - HECking the sexual dimorphism of the immune response” Thanks Jakub for your visit!

submitted 75 days ago • 0 comments

Check this last study led by Nathalie Pujol on skin damage in C. elegans 🪱 just published in PLOS Genetics 👇

submitted 80 days ago • 0 comments

Today, we had the pleasure of welcoming Dr. Filipe Pereira from Lund University in Sweden, as part of the 2025 CIML seminar series. Filipe gave an incredible seminar on "In Vivo Dendritic Cell Reprogramming for Cancer Immunotherapy". Thanks Filipe for your visit!

submitted 88 days ago • 0 comments

🔬 🦠 Check this great scientific meeting organized by Wolfgang Kastenmueller, Menna Clatworthy and CIML's team leader Marc Bajenoff.

submitted 89 days ago • 0 comments

We are proud to announce that the AIR-MT project has been selected for funding by Inserm ImpactSanté program (€3M), with CIML researcher Béatrice Nal as a key partner. The project will use artificial intelligence to design optimized RNAs for more effective vaccines and therapies. #France2030.

submitted 91 days ago • 0 comments

We are proud to announce that the ANTIBAX project has been selected for funding by Inserm (€2.3M), with CIML team leader Pierre Milpied as main partner. Pierre’s team will identify antibodies in tumors that target cancer-causing bacteria, paving the way for new treatments against mucosal cancers.

submitted 95 days ago • 1 comment

Today, we had the pleasure of welcoming Dr. Nelson Gekara from the Institute of Microbiology and Hygiene in Freiburg, as part of the 2025 CIML seminar series. Nelson gave a fantastic talk on "The cross-talks between the innate immune and DNA repair system". Thanks Nelson for your visit!

submitted 95 days ago • 0 comments

Today, we had the pleasure of welcoming Dr. Steeve Boulant from the University of Florida, as part of the 2025 CIML seminar series. Steeve gave a great talk on "Type III Interferons: from regulation of antiviral response to promoting barrier function". Thanks @boulantlab.bsky.social for your visit!

submitted 97 days ago • 0 comments

✊ ♀️ 👩‍🦳 #8mars | À l'occasion de la #JournéeDesDroitsDesFemmes demain, découvrez 10 portraits de femmes travaillant au @cnrs.fr en Provence et qui ont été mises à l'honneur et distinguées lors des derniers mois.

submitted 101 days ago • 12 comments

The CIML supports the movement #StandUpForScience2025 and expresses its solidarity with scientists working in the United States, where academic freedom is currently being challenged. Gather at 12:00 pm at the Natural History Museum, Palais Longchamp, Marseille. @cnrs.fr @inserm.fr @univ-amu.fr

submitted 101 days ago • 0 comments

Today, we had the honor of welcoming Dr. Kim Good Jacobson from Monash University, Melbourne, to kick off the 2025 CIML seminar series. Kim gave a brilliant talk on "Molecular Regulation of Antibody and Immune Memory Responses to Viral Infections". Thanks @kimljacobson.bsky.social for your visit!

submitted 102 days ago • 0 comments

Today, we celebrate International Women’s Day in Science. To honor this day, we've created seven portraits of ♀️ scientists at CIML. Each portrait reflects their unique journey and contributions. Stay tuned for their inspiring stories. #WomenInScience @inserm.fr @cnrs.bsky.social @univ-amu.fr

submitted 125 days ago • 8 comments

The team of Pierre Milpied at CIML, in collaboration with Amédée Renand and Sophie Conchon's teams in Nantes, studied circulating autoreactive T cells in patients with autoimmune hepatitis by single cell RNA-seq and identified tissue-imprinting signatures. Check the study: @naturecomms.bsky.social.

submitted 137 days ago • 0 comments

In a study led by Sylvie Mémet and Jean-Pierre Gorvel, CIML researchers identified a new pathway by which Brucella abortus escapes host immune responses in the visceral fat. Congrats to 1st authors Joaquin Pellegrini, Gabriela González and all collaborators. Check the study: @naturecomms.bsky.social

submitted 144 days ago • 0 comments

The team of Pierre Milpied has just released a new method that links single-cell RNA sequencing with monoclonal antibody production: FB5P-seq-mAbs. This innovation provides a robust and cost-effective way to study B cell responses and rare populations. www.frontiersin.org/journals/imm...

submitted 181 days ago • 0 comments

Last week we had the great honor to welcome Dr. Cecilia Johanssen from Imperial College London in our CIML seminar series. Cecilia gave a brilliant seminar on "Type I interferons in respiratory viral infections and lung cancer" and had lots of exchange with CIML scientists.

submitted 185 days ago • 0 comments

We are proud to announce that two of our distinguished immunologists, Bernard Malissen and Eric Vivier, have been recognized as Highly Cited Researchers by @clarivate.com , with research publications ranking in the top 1% of citations in their field over the past decade.

submitted 185 days ago • 0 comments

@irlalab.bsky.social and collaborators reveals that RANKL therapy reverses age-related thymic decline, recovering immune health in older adults by restoring youthful T-cell responses to vaccines and tumors. Check their study in Science Translational Medicine. www.science.org/doi/10.1126/... .

submitted 185 days ago • 0 comments

Welcome to the BlueSky account of the Centre d’Immunologie de Marseille-Luminy (CIML). 🌟 Founded in 1976, we’re one of Europe’s largest and most prestigious immunology research centers, located in the heart of the Calanques National Park. 🏞️

submitted 202 days ago • 1 comment